HEADER HYDROLASE 14-JUN-06 2IVP TITLE STRUCTURE OF UP1 PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: O-SIALOGLYCOPROTEIN ENDOPEPTIDASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: UP1, GLYCOPROTEASE; COMPND 5 EC: 3.4.24.57; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS ABYSSI; SOURCE 3 ORGANISM_TAXID: 29292; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: ROSETTA (DE3) PLYSS; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS UP1 KEOPS COMPLEX, FE/ZN DEPENDENT NUCLEOTIDE PHOSPHATASE, KEYWDS 2 METALLOPROTEASE, HYPOTHETICAL PROTEIN, ZINC, PROTEASE, HYDROLASE, KEYWDS 3 METAL-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR A.HECKER,N.LEULLIOT,M.GRAILLE,P.DORLET,S.QUEVILLON-CHERUEL,N.ULRYCK, AUTHOR 2 H.VAN TILBEURGH,P.FORTERRE REVDAT 5 08-MAY-24 2IVP 1 LINK REVDAT 4 24-FEB-09 2IVP 1 VERSN REVDAT 3 06-NOV-07 2IVP 1 JRNL REVDAT 2 11-SEP-07 2IVP 1 JRNL REVDAT 1 31-JUL-07 2IVP 0 JRNL AUTH A.HECKER,N.LEULLIOT,D.GADELLE,M.GRAILLE,A.JUSTOME,P.DORLET, JRNL AUTH 2 C.BROCHIER,S.QUEVILLON-CHERUEL,E.LE CAM,H.VAN TILBEURGH, JRNL AUTH 3 P.FORTERRE JRNL TITL AN ARCHAEAL ORTHOLOGUE OF THE UNIVERSAL PROTEIN KAE1 IS AN JRNL TITL 2 IRON METALLOPROTEIN WHICH EXHIBITS ATYPICAL DNA-BINDING JRNL TITL 3 PROPERTIES AND APURINIC-ENDONUCLEASE ACTIVITY IN VITRO. JRNL REF NUCLEIC ACIDS RES. V. 35 6042 2007 JRNL REFN ISSN 0305-1048 JRNL PMID 17766251 JRNL DOI 10.1093/NAR/GKM554 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 10219 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 516 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 720 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3260 REMARK 3 BIN FREE R VALUE SET COUNT : 33 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2499 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.60000 REMARK 3 B22 (A**2) : -1.43000 REMARK 3 B33 (A**2) : 0.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 2.914 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.358 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.241 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.860 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.890 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2576 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3484 ; 1.113 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 324 ; 5.220 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 106 ;35.116 ;23.113 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 449 ;14.771 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;18.877 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 395 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1900 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1090 ; 0.183 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1768 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 58 ; 0.133 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 27 ; 0.148 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 1 ; 0.159 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1660 ; 0.452 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2563 ; 0.780 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1042 ; 1.035 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 921 ; 1.737 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2IVP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1290029117. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.74005 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11607 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.60 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.20 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.84400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.15300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.95700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.15300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.84400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.95700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 326 REMARK 465 HIS A 327 REMARK 465 HIS A 328 REMARK 465 HIS A 329 REMARK 465 HIS A 330 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 10 -131.56 -128.46 REMARK 500 SER A 19 -168.33 -102.66 REMARK 500 ASP A 122 80.92 -153.34 REMARK 500 ASP A 151 -89.33 -134.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FE2 A1326 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 107 NE2 REMARK 620 2 TYR A 127 OH 90.5 REMARK 620 3 ASP A 285 OD1 86.5 175.5 REMARK 620 4 ATP A1327 O1G 123.8 69.4 109.8 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FE2 A1326 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A1327 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IVN RELATED DB: PDB REMARK 900 STRUCTURE OF UP1 PROTEIN REMARK 900 RELATED ID: 2IVO RELATED DB: PDB REMARK 900 STRUCTURE OF UP1 PROTEIN DBREF 2IVP A 1 324 UNP Q9UXT7 GCP_PYRAB 1 324 DBREF 2IVP A 325 330 PDB 2IVP 2IVP 325 330 SEQRES 1 A 330 MET LEU ALA LEU GLY ILE GLU GLY THR ALA HIS THR LEU SEQRES 2 A 330 GLY ILE GLY ILE VAL SER GLU ASP LYS VAL LEU ALA ASN SEQRES 3 A 330 VAL PHE ASP THR LEU THR THR GLU LYS GLY GLY ILE HIS SEQRES 4 A 330 PRO LYS GLU ALA ALA GLU HIS HIS ALA ARG LEU MET LYS SEQRES 5 A 330 PRO LEU LEU ARG LYS ALA LEU SER GLU ALA GLY VAL SER SEQRES 6 A 330 LEU ASP ASP ILE ASP VAL ILE ALA PHE SER GLN GLY PRO SEQRES 7 A 330 GLY LEU GLY PRO ALA LEU ARG VAL VAL ALA THR ALA ALA SEQRES 8 A 330 ARG ALA LEU ALA VAL LYS TYR ARG LYS PRO ILE VAL GLY SEQRES 9 A 330 VAL ASN HIS CYS ILE ALA HIS VAL GLU ILE THR LYS MET SEQRES 10 A 330 PHE GLY VAL LYS ASP PRO VAL GLY LEU TYR VAL SER GLY SEQRES 11 A 330 GLY ASN THR GLN VAL LEU ALA LEU GLU GLY GLY ARG TYR SEQRES 12 A 330 ARG VAL PHE GLY GLU THR LEU ASP ILE GLY ILE GLY ASN SEQRES 13 A 330 ALA ILE ASP VAL PHE ALA ARG GLU LEU GLY LEU GLY PHE SEQRES 14 A 330 PRO GLY GLY PRO LYS VAL GLU LYS LEU ALA GLU LYS GLY SEQRES 15 A 330 GLU LYS TYR ILE GLU LEU PRO TYR ALA VAL LYS GLY MET SEQRES 16 A 330 ASP LEU SER PHE SER GLY LEU LEU THR GLU ALA ILE ARG SEQRES 17 A 330 LYS TYR ARG SER GLY LYS TYR ARG VAL GLU ASP LEU ALA SEQRES 18 A 330 TYR SER PHE GLN GLU THR ALA PHE ALA ALA LEU VAL GLU SEQRES 19 A 330 VAL THR GLU ARG ALA VAL ALA HIS THR GLU LYS ASP GLU SEQRES 20 A 330 VAL VAL LEU VAL GLY GLY VAL ALA ALA ASN ASN ARG LEU SEQRES 21 A 330 ARG GLU MET LEU ARG ILE MET THR GLU ASP ARG GLY ILE SEQRES 22 A 330 LYS PHE PHE VAL PRO PRO TYR ASP LEU CYS ARG ASP ASN SEQRES 23 A 330 GLY ALA MET ILE ALA TYR THR GLY LEU ARG MET TYR LYS SEQRES 24 A 330 ALA GLY ILE SER PHE ARG LEU GLU GLU THR ILE VAL LYS SEQRES 25 A 330 GLN LYS PHE ARG THR ASP GLU VAL GLU ILE VAL TRP HIS SEQRES 26 A 330 HIS HIS HIS HIS HIS HET FE2 A1326 1 HET ATP A1327 31 HETNAM FE2 FE (II) ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 2 FE2 FE 2+ FORMUL 3 ATP C10 H16 N5 O13 P3 HELIX 1 1 HIS A 39 GLY A 63 1 25 HELIX 2 2 LEU A 80 TYR A 98 1 19 HELIX 3 3 HIS A 107 ILE A 114 1 8 HELIX 4 4 THR A 115 GLY A 119 5 5 HELIX 5 5 GLY A 153 LEU A 165 1 13 HELIX 6 6 PRO A 170 LYS A 181 1 12 HELIX 7 7 PHE A 199 GLY A 213 1 15 HELIX 8 8 ARG A 216 GLU A 244 1 29 HELIX 9 9 GLY A 252 ALA A 256 5 5 HELIX 10 10 ASN A 257 ARG A 271 1 15 HELIX 11 11 PRO A 279 CYS A 283 5 5 HELIX 12 12 ASN A 286 ALA A 300 1 15 HELIX 13 13 ARG A 305 ILE A 310 5 6 HELIX 14 14 ARG A 316 VAL A 320 5 5 SHEET 1 AA 5 VAL A 23 THR A 30 0 SHEET 2 AA 5 THR A 12 VAL A 18 -1 O LEU A 13 N ASP A 29 SHEET 3 AA 5 ALA A 3 GLU A 7 -1 O ALA A 3 N VAL A 18 SHEET 4 AA 5 VAL A 71 GLY A 77 1 O VAL A 71 N LEU A 4 SHEET 5 AA 5 ILE A 102 ASN A 106 1 O VAL A 103 N PHE A 74 SHEET 1 AB 5 TYR A 143 GLU A 148 0 SHEET 2 AB 5 THR A 133 LEU A 138 -1 O VAL A 135 N PHE A 146 SHEET 3 AB 5 VAL A 124 VAL A 128 -1 O GLY A 125 N LEU A 136 SHEET 4 AB 5 GLU A 247 VAL A 251 1 O GLU A 247 N VAL A 124 SHEET 5 AB 5 LYS A 274 PHE A 276 1 O LYS A 274 N VAL A 248 SHEET 1 AC 2 VAL A 192 LYS A 193 0 SHEET 2 AC 2 ASP A 196 LEU A 197 -1 O ASP A 196 N LYS A 193 LINK NE2 HIS A 107 FE FE2 A1326 1555 1555 2.25 LINK OH TYR A 127 FE FE2 A1326 1555 1555 2.35 LINK OD1 ASP A 285 FE FE2 A1326 1555 1555 2.29 LINK FE FE2 A1326 O1G ATP A1327 1555 1555 2.47 CISPEP 1 GLY A 77 PRO A 78 0 -3.90 CISPEP 2 PHE A 169 PRO A 170 0 1.01 SITE 1 AC1 5 HIS A 107 HIS A 111 TYR A 127 ASP A 285 SITE 2 AC1 5 ATP A1327 SITE 1 AC2 18 THR A 9 HIS A 107 TYR A 127 SER A 129 SITE 2 AC2 18 GLY A 130 GLY A 131 ASN A 132 GLY A 155 SITE 3 AC2 18 ASP A 159 GLY A 172 GLU A 176 GLY A 253 SITE 4 AC2 18 ALA A 256 ASN A 257 TYR A 280 ARG A 284 SITE 5 AC2 18 ASP A 285 FE2 A1326 CRYST1 61.688 69.914 74.306 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016211 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014303 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013458 0.00000